AbCellera Biologics Inc. Common Shares ABCL
$10.97
+5.94%
at last close
Analyst Consensus
- Consensus Rating
- Buy (5 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $12.83
- Implied Upside
- +17.0%
- Price Target Range
- $4.00 – $30.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-11 | Truist SecuritiesRobyn Kamaus |
Maintains | Buy | $12 → $30 |
| 2026-08-06 | StifelStephen Willey |
Maintains | Buy | $8 → $9 |
| 2026-08-06 | Cantor FitzgeraldSteve Seedhouse |
Maintains | Overweight | $11 → $12 |
| 2026-07-07 | BenchmarkRobert Wasserman |
Upgrades | Hold → Buy | $11 |
| 2026-05-05 | Cantor FitzgeraldSteve Seedhouse |
Initiates coverage on | Overweight | $7 |
| 2026-04-10 | Jones TradingDebanjana Chatterjee |
Initiates coverage on | Buy | $11 |
| 2025-11-07 | Leerink PartnersFaisal Khurshid |
Downgrades | Outperform → Market perform | $4 |
| 2025-08-08 | StifelStephen Willey |
Maintains | Buy | $8 → $7 |
| 2025-07-14 | KeybancScott Schoenhaus |
Maintains | Overweight | $5 → $10 |
| 2025-07-07 | Leerink PartnersFaisal Khurshid |
Assumes | Outperform | $5 |
| 2025-05-16 | Truist SecuritiesRobyn Karnauskas |
Maintains | Buy | $28 → $10 |
| 2025-04-16 | KeybancScott Schoenhaus |
Maintains | Overweight | $4 → $5 |
| 2025-03-03 | BenchmarkRobert Wasserman |
Reiterates | Hold | — |
| 2025-02-28 | StifelStephen Willey |
Maintains | Buy | $12 → $10 |
| 2025-01-08 | KeybancScott Schoenhaus |
Maintains | Overweight | $5 → $4 |
| 2024-11-05 | BenchmarkRobert Wasserman |
Reiterates | Hold | — |
| 2024-11-05 | StifelStephen Willey |
Reiterates | Buy | $14 → $12 |
| 2024-08-20 | BenchmarkRobert Wasserman |
Downgrades | Buy → Hold | — |
| 2024-07-11 | KeybancScott Schoenhaus |
Maintains | Overweight | $7 → $5 |
| 2024-05-08 | KeybancScott Schoenhaus |
Maintains | Overweight | $8 → $7 |
| 2024-02-22 | BenchmarkRobert Wasserman |
Upgrades | Hold → Buy | — |
| 2024-02-21 | StifelStephen Willey |
Maintains | Buy | $21 → $17 |
| 2023-12-05 | KeybancScott Schoenhaus |
Initiates coverage on | Overweight | $6 |
| 2023-10-13 | Piper SandlerAllison Bratzel |
Assumes | Overweight | $20 |
| 2023-08-31 | BenchmarkRobert Wasserman |
Maintains | Buy | $20 → $12 |
| 2023-08-04 | Goldman SachsAndrea Tan |
Maintains | Buy | $27 → $24 |
| 2023-05-05 | Credit SuisseTiago Fauth |
Maintains | Outperform | $34 → $28 |
| 2023-02-28 | Cowen & Co.Steven Mah |
Initiates coverage on | Outperform | — |
| 2023-02-22 | BMO CapitalGary Nachman |
Maintains | Outperform | $40 → $32 |
| 2023-02-22 | Credit SuisseTiago Fauth |
Reiterates | Outperform | $34 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $10.97
- Market Cap
- $3.17 billion
- 52-Week Range
- $2.75 – $11.06
- Average Volume
- 8.16 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.